Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors.

The goal of this study was to determine whether presurgical metabolite levels measured by 3D MR Spectroscopic Imaging (MRSI) can accurately detect viable cancer within human brain tumor masses. A total of 31 patients (33 exams, 39 pathology correlations) with brain tumors were studied prior to surgical biopsy and/or resection. The 3D MRSI was obtained with a spatial resolution of 0.2 to 1 cc throughout the majority of the mass and adjacent brain tissue using PRESS-CSI localization. Levels of choline, creatine and NAA were estimated from the locations of the resected tissue and normalized to normal appearing brain tissue. The data were correlated with subsequent histologic analysis of the biopsy tissue samples. Although there were large variations in the metabolite ratios, all regions of confirmed cancer demonstrated significant choline levels and a mean choline/NAA ratio of 5.84 + 2.58 with the lowest value being 1.3. This lowest value is greater than 4 standard deviations above the mean (0.52 +/- 0.13) found in 8 normal volunteers. The choline signal intensities in confirmed cancers were significantly elevated compared to normal appearing brain tissue with a mean ratio of 1.71 +/- 0.69. Spectra with no significant metabolite levels were observed in the non-enhancing necrotic core of the tumor masses. The results of this study indicate that 3D MRSI of brain tumors can detect abnormal metabolite levels in regions of viable cancer and grades and can differentiate cancer from necrosis and/or normal brain tissue.

[1]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[2]  J. Pauly,et al.  Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm [NMR imaging]. , 1991, IEEE transactions on medical imaging.

[3]  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. , 1997 .

[4]  J. Pruim,et al.  Contribution of Magnetic Resonance Spectroscopic Imaging and L-[1-11C]Tyrosine Positron Emission Tomography to Localization of Cerebral Gliomas for Biopsy , 1994 .

[5]  S. Nelson,et al.  Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI , 1999, NMR in biomedicine.

[6]  Susan M. Chang,et al.  Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: Presentation of a detailed case study , 1997, Journal of magnetic resonance imaging : JMRI.

[7]  D. Jenden,et al.  Localized In Vivo 1H Magnetic Resonance Spectroscopy and In Vitro Analyses of Heterogeneous Brain Tumors , 1995, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[8]  R. Kauppinen,et al.  Choline‐Containing Compounds in Human Astrocytomas Studied by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of neurochemistry.

[9]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[10]  J A Frank,et al.  Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.

[11]  J. Bruner,et al.  Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors , 1993, Annals of neurology.

[12]  P R Luyten,et al.  Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.

[13]  D B Vigneron,et al.  Registration of images from sequential MR studies of the brain , 1994, Journal of magnetic resonance imaging : JMRI.

[14]  Y. Kinoshita,et al.  Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. , 1994, Neurosurgery.

[15]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[16]  C Van Ongeval,et al.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.

[17]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[18]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[20]  S K Hilal,et al.  In vivo MR spectroscopic imaging with P-31. Work in progress. , 1984, Radiology.

[21]  Susan M. Chang,et al.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. , 1997, Journal of neurosurgery.

[22]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[23]  J. Saunders,et al.  Classification of Brain Tumors by Ex Vivo 1H NMR Spectroscopy , 1995, Journal of neurochemistry.

[24]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[25]  S. Nelson,et al.  Surface coil MR imaging of the human brain with an analytic reception profile correction , 1995, Journal of magnetic resonance imaging : JMRI.

[26]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[27]  Y. Kinoshita,et al.  Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study. , 1993, Neurologia medico-chirurgica.

[28]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[29]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[30]  D. Leibfritz,et al.  Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla--first results. , 1989, Magnetic resonance imaging.

[31]  Thomas H. Mareci,et al.  High-resolution magnetic resonance spectra from a sensitive region defined with pulsed field gradients , 1984 .

[32]  Hidehiko Kajiwara,et al.  Proton Magnetic Resonance Spectroscopy of Brain TumorsAn In Vitro Study , 1994 .

[33]  L L Wald,et al.  Proton spectroscopic imaging of the human brain using phased array detectors , 1995, Magnetic resonance in medicine.

[34]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[35]  G B Matson,et al.  3D phase encoding 1H spectroscopic imaging of human brain. , 1992, Magnetic resonance imaging.

[36]  D Fewer,et al.  Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy , 1996, Journal of magnetic resonance imaging : JMRI.